Lv51
905 积分 2021-07-08 加入
Evolving roles of MET as a therapeutic target in NSCLC and beyond
1个月前
已完结
DNAJ-PKAc fusion heightens PLK1 inhibitor sensitivity in fibrolamellar carcinoma
2个月前
已完结
LY2875358, a Neutralizing and Internalizing Anti-MET Bivalent Antibody, Inhibits HGF-Dependent and HGF-Independent MET Activation and Tumor Growth
2个月前
已完结
Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer
2个月前
已完结
Chromosome 1q21.3 amplification is a trackable biomarker and actionable target for breast cancer recurrence
2个月前
已完结
A Promoter Haplotype of the Immunoreceptor Tyrosine-Based Inhibitory Motif-Bearing FcγRIIb Alters Receptor Expression and Associates with Autoimmunity. I. Regulatory FCGR2B Polymorphisms and Their Association with Systemic Lupus Erythematosus
2个月前
已完结
Decreased transcription of the human FCGR2B gene mediated by the -343 G/C promoter polymorphism and association with systemic lupus erythematosus
2个月前
已完结
CRISPR-Cas9 screens identify regulators of antibody–drug conjugate toxicity
2个月前
已完结
Targeting PLK1 overcomes T-DM1 resistance via CDK1-dependent phosphorylation and inactivation of Bcl-2/xL in HER2-positive breast cancer
2个月前
已完结
HGF/Met and FOXM1 form a positive feedback loop and render pancreatic cancer cells resistance to Met inhibition and aggressive phenotypes
2个月前
已完结
皖公网安备34019202002308
